To this end, a relevant, publicly available gene expression dataset was used, in which Pishas and colleagues [34] treated Ewing sarcoma cells with increasing concentrations of SP-2509 to investigate the mechanisms underlying the resistance to SP-2509, a small molecular reversible inhibitor of LSD1 [76], in sarcoma. Here, KDM1A is linked to sarcoma.